Abstract
Hundreds of predictions about the duration of the pandemic and the number of infected and dead have been carried out using traditional epidemiological tools (i.e. SIR, SIRD models, etc.) or new procedures of big-data analysis. However, the extraordinary complexity of the disease and the lack of knowledge about the pandemic (i.e. R value, mortality rate, etc.) create uncertainty about the accuracy of these estimates. However, several elegant mathematical approaches, based on physics and probability principles, like the Delta-t argument, Lindy’s Law or the Doomsday principle-Carter’s catastrophe, which have been successfully applied by scientists to unravel complex phenomena characterized by their great uncertainty (i.e. Human race’s longevity; How many more humans will be born before extinction) allow predicting parameters of the Covid-19 pandemic. These models predict that the COVID-19 pandemic will hit us until at least September-October 2021, but will likely last until January-September 2022, causing a minimum of 36,000,000 infected and most likely 60,000,000, as well as 1,400,000 dead at best and most likely 2,333,000.
Competing Interest Statement
The authors have declared no competing interest.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was required to develop this paper
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Complutense University Madrid
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data was obtained from public web pages and links are available in the manuscript
